Sign In
Buy AXDX
$0.0340
+0 (+0%)
At Close: Aug 12, 2025
Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
11:09am, Thursday, 08'th Aug 2024
TUCSON, Ariz. , Aug. 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced that management will host a conference call today, Thursday, August 8, 2024, at 4:30 p.m.
Dead Cat Bounce: 3 Stocks to Sell Before They Plunge Again
12:05pm, Thursday, 13'th Jun 2024
A dead cat bounce is when a falling stock sees a short-term recovery, but is ultimately likely to head lower. It comes from the idea that “even a dead cat will bounce if it falls from a great height
Accelerate Diagnostics, Inc. (AXDX) Q1 2024 Earnings Call Transcript
07:50pm, Wednesday, 08'th May 2024
Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Laura Pierson - Investor Relations Officer Jack Phillips - Chief Executive Offi
Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates
07:26pm, Wednesday, 08'th May 2024
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $1.70 per share a year ago.
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
04:42pm, Wednesday, 08'th May 2024
TUCSON, Ariz. , May 8, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024.
Will Accelerate Diagnostics (AXDX) Report Negative Q1 Earnings? What You Should Know
11:06am, Thursday, 02'nd May 2024
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
09:30am, Thursday, 02'nd May 2024
TUCSON, Ariz. , May 2, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m.
Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript
07:50pm, Thursday, 28'th Mar 2024
Accelerate Diagnostics Inc. (AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
06:46pm, Thursday, 28'th Mar 2024
Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.89 per share versus the Zacks Consensus Estimate of a loss of $0.62. This compares to loss of $1.40 per share a year ago.
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
04:05pm, Thursday, 28'th Mar 2024
TUCSON, Ariz. , March 28, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023.
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
09:30am, Thursday, 07'th Mar 2024
TUCSON, Ariz. , March 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30 p.m.
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
09:20am, Friday, 19'th Jan 2024
TUCSON, Ariz. , Jan. 19, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the pricing of an underwritten public offering consisting of 6,860,659 units,
Accelerate Diagnostics Announces Launch of Proposed Public Offering
07:45am, Tuesday, 16'th Jan 2024
TUCSON, Ariz. , Jan. 16, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) (the "Company") today announced the launch of a proposed underwritten public offering of 4,500,000 units, each
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
08:00pm, Sunday, 07'th Jan 2024
TUCSON, Ariz. , Jan. 7, 2024 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) (Accelerate), an in vitro diagnostics company dedicated to providing services that improve patient outcomes a
Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics
09:46am, Wednesday, 29'th Nov 2023
Accelerate Diagnostics' (AXDX) Arc system eliminates the need for overnight culture incubation, drastically reducing the wait time for identification results.
